| Capacity to utilize raffinose dictates pneumococcal disease phenotype V Minhas, RM Harvey, LJ McAllister, T Seemann, AE Syme, SL Baines, ... MBio 10 (1), 10.1128/mbio. 02596-18, 2019 | 32 | 2019 |
| In vivo dual RNA-seq reveals that neutrophil recruitment underlies differential tissue tropism of Streptococcus pneumoniae V Minhas, R Aprianto, LJ McAllister, H Wang, SC David, KT McLean, ... Communications biology 3 (1), 293, 2020 | 27* | 2020 |
| Host-glycan metabolism is regulated by a species-conserved two-component system in Streptococcus pneumoniae PR Andreassen, C Trappetti, V Minhas, FD Nielsen, K Pakula, JC Paton, ... PLoS pathogens 16 (3), e1008332, 2020 | 14 | 2020 |
| Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine SC David, Z Laan, V Minhas, AY Chen, J Davies, TR Hirst, SR McColl, ... Immunology and Cell Biology 97 (8), 726-739, 2019 | 14 | 2019 |
| Competence remodels the pneumococcal cell wall exposing key surface virulence factors that mediate increased host adherence V Minhas, A Domenech, D Synefiaridou, D Straume, M Brendel, ... PLoS Biology 21 (1), e3001990, 2023 | 13 | 2023 |
| Site-specific mutations of GalR affect galactose metabolism in streptococcus pneumoniae KT McLean, A Tikhomirova, EB Brazel, S Legendre, G Haasbroek, ... Journal of bacteriology 203 (1), 10.1128/jb. 00180-20, 2020 | 11 | 2020 |
| Sickly sweet–how sugar utilization impacts pneumococcal disease progression V Minhas, JC Paton, C Trappetti Trends in Microbiology 29 (9), 768-771, 2021 | 9 | 2021 |
| A nonadjuvanted whole-inactivated pneumococcal vaccine induces multiserotype opsonophagocytic responses mediated by noncapsule-specific antibodies SC David, EB Brazel, EV Singleton, V Minhas, Z Laan, C Scougall, ... Mbio 13 (5), e02367-22, 2022 | 2 | 2022 |
| Pathogenesis of Streptococcus pneumoniae-a molecular characterisation V Minhas | 1 | 2020 |
